Jobs / United States / Astrazeneca Pharmaceuticals Lp

Astrazeneca Pharmaceuticals Lp

Project Toxicologist, Director – Oncology Targeted Delivery (OTD) Safety Science, Clinical Pharmacology and Safety Sciences (Cambridge, MA or Gaithersburg, MD)

US - Gaithersburg - MD Posted today

Apply on employer site ↗ Tailor my CV first Source: Company careers site

Optional: we can tailor a CV and cover letter for this job from your real experience first (the first one is free).

Sponsorship verdict

Sponsorship possible

One solid signal, not two. Worth applying, and worth asking about sponsorship early.

  • Employer is on a government sponsor recordThe US Department of Labor certified 99 H-1B/E-3 labor condition applications for this employer between Oct 2025 and Jun 2026 (latest Jun 2026) — the step every H-1B hire needs first.
  • The posting doesn’t mention sponsorshipSilence isn’t a refusal — ask the recruiter before investing much time.
  • No salary bar for this routeH-1B has no fixed salary bar: the employer must pay at least the prevailing wage for the role and area.
  • What Astrazeneca Pharmaceuticals Lp paid sponsored hires in similar roles15 certified filings for “Associate Director Oncology Outcomes Research” (Medical Scientists, Except Epidemiologists) in MD: $126k–$185k, median $140k.
  • Confirmed live todayWhen a source last listed this job as open.
Details and sources
Employer is on a government sponsor record
The US Department of Labor certified 99 H-1B/E-3 labor condition applications for this employer between Oct 2025 and Jun 2026 (latest Jun 2026) — the step every H-1B hire needs first. Source: LCA disclosure data (US Department of Labor (OFLC)).
No salary bar for this route
H-1B has no fixed salary bar: the employer must pay at least the prevailing wage for the role and area. Cap-subject employers enter a lottery weighted by wage level. Source: https://www.federalregister.gov/documents/2025/12/29/2025-23853/weighted-selection-process-for-registrants-and-petitioners-seeking-to-file-cap-subject-h-1b, rules effective 2026-02-27.
What Astrazeneca Pharmaceuticals Lp paid sponsored hires in similar roles
15 certified filings for “Associate Director Oncology Outcomes Research” (Medical Scientists, Except Epidemiologists) in MD: $126k–$185k, median $140k. Most were filed at wage level II (47%) — 2 lottery entries, ≈31% projected selection odds for cap-subject employers. Source: US Department of Labor LCA disclosure data (Oct 2025 – Jun 2026).

US H-1B: cap-subject employers enter a lottery weighted by wage level — Level I gets 1 entry, Level IV gets 4 (DHS projected selection odds ≈15% at Level I to ≈61% at Level IV). Universities and non-profit research employers are cap-exempt. The $100,000 fee for new petitions from abroad is currently blocked by a court order (appeal pending).

A verdict summarises public evidence. It is not legal advice and never a guarantee: the employer and the immigration authority decide. Sign in to factor in where you can already work.

About the role

At  AstraZeneca , our ambition is to eliminate cancer as a cause of death. Our pioneering oncology pipeline reflects this mission, and our  Oncology Targeted Delivery (OTD) Safety team  plays a critical role in advancing transformative therapies to patients. We are seeking a passionate and highly motivated  Director, Project Toxicologist  to join our OTD Safety group. This role will focus on novel targeted oncology therapies, including  radioconjugates, antibody–drug conjugates (ADCs), and small molecules . Experience with radioconjugates is particularly valued; however, candidates with expertise in other relevant modalities are encouraged to apply. As a Project Toxicologist, you will partner with cross-functional teams across Oncology R&D, bridging discovery and regulatory toxicology. You will develop innovative safety strategies, guide candidate selection, inform regulatory approaches, and help shape the future of oncology safety science. LOCATIONS: Cambridge, MA (Kendall Square) or Gaithersburg, MD What you’ll do • Lead toxicology strategies : Design and oversee regulatory and investigative toxicology programs to predict, assess, and mitigate target- and modality-related safety risks. • Support development decisions : Apply your toxicology expertise to anticipate clinical safety risks and provide data-driven recommendations across discovery and development programs. • Advance safety science : Integrate in vitro, in silico, and in vivo approaches with emerging technologies, including organ-on-chip, imaging, and omics, to address complex safety questions. • Communicate integrated risk assessments : Present scientific conclusions and safety strategies to governance bodies and contribute to regulatory submissions. • Provide regulatory and scientific leadership : Maintain and expand expertise in regulatory standards, preclinical safety, and modality-specific toxicology while anticipating industry trends and evolving methodologies. • Support external opportunities : Provide strategic toxicology input for in-licensing evaluations, due diligence activities, and external collaborations. • Build scientific influence : Advance Oncology Safety science through internal and external collaborations, publications, conference participation, and thought leadership. • Develop people and partnerships : Contribute to an inclusive, collaborative environment and support the development of colleagues across teams and geographies. Essential qualifications and experience • Education : PhD, DABT, or an advanced university degree in toxicology, pharmacology, oncology, or a related scientific discipline, together with a strong scientific track record. • Professional experience : Typically, at least 10 years of experience in project toxicology, investigative toxicology, regulatory toxicology, or related safety-focused roles within the pharmaceutical, biotechnology, or CRO sector. • Alternative experience pathway : Candidates with a minimum bachelor’s degree and substantial additional pharmaceutical industry experience may also be considered, including candidates with approximately 15 or more years of relevant experience. • Oncology expertise : Deep understanding of oncology drug discovery and development, with a demonstrated ability to deliver toxicology programs supporting IND filings and broader development milestones. • Modality expertise : Experience with radioconjugates or ADCs is preferred. Familiarity with small-molecule oncology therapeutics is also valuable. • Translational safety skills : Experience applying in vitro, in silico, and in vivo tools to predict and characterize potential clinical safety risks. • Leadership and collaboration : Ability to coordinate multiple projects across functions and geographies while working eff

Apply on employer site ↗